Brief: Verrica Pharmaceuticals Reports Third Quarter 2022 Financial Results

Verrica Pharmaceuticals

07/11/2022 22:27

Nov 7 (Reuters) - Verrica Pharmaceuticals Inc  VRCA.O :
    * VERRICA PHARMACEUTICALS REPORTS THIRD QUARTER 2022
FINANCIAL
RESULTS
    * SAYS REITERATES EXPECTATION TO RESUBMIT NDA FOR VP-102 FOR
MOLLUSCUM CONTAGIOSUM IN Q1 2023
    * Q3 GAAP EARNINGS PER SHARE $0.00
    * Q3 NON-GAAP EARNINGS PER SHARE $0.07
    * QTRLY LICENSE REVENUES $8.32 MILLION
    * Q3 EARNINGS PER SHARE VIEW $-0.11, REVENUE VIEW $4.3
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX89rSPd 
Further company coverage:  VRCA.O 
 ((Reuters.Briefs@thomsonreuters.com;))